File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Editorial: Translating NK cell scientific research to clinical product manufacturing

TitleEditorial: Translating NK cell scientific research to clinical product manufacturing
Authors
Ullrich, EvelynHuppert, VolkerTonn, TorstenLeung, Wing
KeywordsATMP
cell therapy
good manufacturing practice (GMP)
manufacturing
Natural Killer cells
NK cells
tumor therapy
Issue Date23-Aug-2023
PublisherFrontiers Media
Citation
Frontiers in Immunology, 2023, v. 14 How to Cite?
DOI: http://dx.doi.org/10.3389/fimmu.2023.1229417
Persistent Identifierhttp://hdl.handle.net/10722/337441
ISSN
1664-3224
2021 Impact Factor: 8.786
2020 SCImago Journal Rankings: 2.646

 

DC FieldValueLanguage
dc.contributor.authorUllrich, Evelyn-
dc.contributor.authorHuppert, Volker-
dc.contributor.authorTonn, Torsten-
dc.contributor.authorLeung, Wing-
dc.date.accessioned2024-03-11T10:20:53Z-
dc.date.available2024-03-11T10:20:53Z-
dc.date.issued2023-08-23-
dc.identifier.citationFrontiers in Immunology, 2023, v. 14-
dc.identifier.issn1664-3224-
dc.identifier.urihttp://hdl.handle.net/10722/337441-
dc.languageeng-
dc.publisherFrontiers Media-
dc.relation.ispartofFrontiers in Immunology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectATMP-
dc.subjectcell therapy-
dc.subjectgood manufacturing practice (GMP)-
dc.subjectmanufacturing-
dc.subjectNatural Killer cells-
dc.subjectNK cells-
dc.subjecttumor therapy-
dc.titleEditorial: Translating NK cell scientific research to clinical product manufacturing-
dc.typeArticle-
dc.identifier.doi10.3389/fimmu.2023.1229417-
dc.identifier.scopuseid_2-s2.0-85169906935-
dc.identifier.volume14-
dc.identifier.eissn1664-3224-
dc.identifier.issnl1664-3224-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats